文献速递胃肠外科围术期管理与 ERAS

生物可吸收补片在食管裂孔疝修补中安全性的中期评估

Mid-term safety profile evaluation of Bio-A absorbable synthetic mesh as cruroplasty reinforcement.
PubMed 文献 · Surg Endosc · 2019-01-23

该回顾性研究纳入120例接受生物可吸收合成补片加强的食管裂孔疝修补患者,分为肥胖合并减重手术组(92例)和非肥胖合并抗反流手术组(28例)。中位随访41个月,未发生补片相关并发症,复发率分别为5.4%和7.1%,Cox分析显示修补使用超过4针是复发的负面因素(HR=8;P<0.05)。

要点

  • 生物可吸收补片加强修补未发生补片相关并发症,安全性良好。
  • 肥胖组和非肥胖组复发率分别为5.4%和7.1%,症状控制良好。
  • 修补使用超过4针是复发的独立危险因素(HR=8;P<0.05)。

核心结论

  • 生物可吸收补片用于食管裂孔疝修补具有安全的中期 profile,复发率低且 GERD 症状控制良好。
  • 修补使用超过4针是复发的负面因素(HR=8;P<0.05)。

研究设计与样本

  • 单中心回顾性队列研究,前瞻性维护数据库。
  • 纳入120例连续接受生物可吸收合成补片加强食管裂孔疝修补的患者,平均随访41个月。
  • 分为两组:A组92例肥胖患者行减重手术同期加强修补;B组28例非肥胖患者行抗反流手术同期加强修补。

主要发现

  • 无术中、围手术期及术后补片相关并发症发生。
  • 吞咽困难发生率A组8.7%,B组11%。
  • A组74%、B组61%患者停用PPI,GERD-HRQL中位评分分别从16降至4、从23降至6(术前术后差异<0.05)。
  • 复发率A组5.4%,B组7.1%。
  • Cox风险分析显示使用超过4针进行修补是复发的负面因素(HR=8;P<0.05)。

关键数值与推荐

  • 复发评估采用钡餐X线、必要时CT及内镜;症状评估采用GERD-HRQL和Rome III。
  • 仅纳入平均随访12个月的患者。

临床怎么用

  • 生物可吸收补片可作为食管裂孔疝修补的加强材料,中期安全性良好。
  • 术中应关注修补缝针数量,超过4针可能增加复发风险。

局限性

  • 回顾性研究设计,非随机对照。
  • 单中心经验,样本量有限(120例)。
  • 随访时间中期(平均41个月),缺乏长期数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of the present paper is to report the results of a single institution series of hiatal hernia repair (HHR) with augmented mesh hiatoplasty focusing on safety and efficacy profile of Bio-A absorbable synthetic mesh. MATERIALS AND METHODS: A retrospective evaluation of prospectively maintained database showed 120 consecutive patients submitted to HHR reinforced with bio-absorbable synthetic mesh. The study populations included two groups: (A) 92 obese patients-reinforced hiatoplasty concurrent with bariatric procedure; (B) 28 non-obese patients-reinforced hiatoplasty concurrent with antireflux surgery. Symptoms assessment was made with GERD-HRQL and Rome III. The X-ray with barium swallow, the CT scan, in selected cases, and the endoscopy were used as recurrence evaluation and as endoscopic complications assessment. Only patients with a mean follow-up of 12 months were included in this study. A Cox hazard was made to evaluate factors affecting the recurrence. RESULTS: No case of intra-peri and post-operative (mean follow-up of 41 months) complications mesh related were registered. The dysphagia-rate was 8.7% for Group A and 11% for Group B. 74% of Group A and 61% of Group B patients are actually PPIs free with median GERD-HRQL score of 4 (from 16) and 6 (from 23), respectively (difference pre-post-operative < 0.05). Recurrence rate was 5.4% in Group A and 7.1% in Group B. The Cox hazard analysis showed that the use of more than four stitches for cruroplasty represents a negative factor on recurrence (HR = 8; p < 0.05). CONCLUSIONS: This is, in our knowledge, the largest report (120 consecutive patients) with mid-term follow-up (41 months of mean FU) on bio-absorbable mesh on the hiatus in obese and non-obese patients. These results supports the use of absorbable mesh for HHR (safe profile-0% of complications rate), showing excellent recurrence rate results and good GERD symptoms control.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Iossa A, Silecchia G. Mid-term safety profile evaluation of Bio-A absorbable synthetic mesh as cruroplasty reinforcement. Surg Endosc. 2019. PMID: 30675663. doi:10.1007/s00464-019-06676-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。